Skip to main content
PolicySpeak
← All files
ANE

Asociación Española de Medicamentos Húerfanos y Ultrahuérfanos

Industry association · Spain · EU Transparency Register 429216742750-40

1
position filed
in the 583 files tracked
1
legislative file
of 583 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1365 trade and business associations on this site, they rank #1035 by legislative files engaged — a count of participation, not a measure of influence.

0.3
declared lobbying FTE
self-declared
€10K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2021
in the register since

Declares membership of

  • www.aelmhu.es

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).

Register category
Trade and business associations
Registered as
Asociación Española de laboratorios Huérfanos y Ultrahuérfanos (AELMHU)
Head office
Barcelona, Spain
EU office
Madrid

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Asociación in PolicySpeak: request access →

Work at Asociación Española de Medicamentos Húerfanos y Ultrahuérfanos? so we know who speaks for it.

Follow the file Asociación Española de Medicamentos Húerfanos y Ultrahuérfanos engages with

One email on Tuesdays when a new position is filed on this file, from Asociación Española de Medicamentos Húerfanos y Ultrahuérfanos or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Asociación Española de Medicamentos Húerfanos y Ultrahuérfanos filed 1 position on 6 Nov 2023, across 1 of the 583 legislative files tracked here, attaching a full position paper 1 time.

What they argued

Medicinal products for human usefiled 6 Nov 2023PDFsource

AELMHU, Asociación Española de Laboratorios de Medicamentos Huérfanos y Ultrahuérfanos, a non-profit organization that brings together 25 biotechnology and pharmaceutical companies committed to the discovery, research, development and commercialization of innovative therapies capable of improving the situation of patients living with rare and ultra-rare diseases, appreciates the opportunity to participate in this…

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Asociación Española de Medicamentos Húerfanos y Ultrahuérfanos next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from Asociación Española de Medicamentos Húerfanos y Ultrahuérfanos’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.